OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 85 citing articles:

Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study
Mohamed Farouk Chughlay, Myriam El Gaaloul, Cristina Donini, et al.
American Journal of Tropical Medicine and Hygiene (2021) Vol. 104, Iss. 4, pp. 1348-1358
Open Access | Times Cited: 28

Expression Patterns of Plasmodium falciparum Clonally Variant Genes at the Onset of a Blood Infection in Malaria-Naive Humans
Anastasia K. Pickford, Lucas Michel-Todó, Florian Dupuy, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 28

Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
Said Jongo, L. W. Preston Church, Vicente Urbano Nsue Ndong Nchama, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1215-1226
Open Access | Times Cited: 21

Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers
Matthew B. B. McCall, Linda J. Wammes, Marijke C. C. Langenberg, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 395
Closed Access | Times Cited: 39

Development of whole sporozoite malaria vaccines
Michael R. Hollingdale, Martha Sedegah
Expert Review of Vaccines (2016) Vol. 16, Iss. 1, pp. 45-54
Closed Access | Times Cited: 37

Current therapies and future possibilities for drug development against liver-stage malaria
Rene Raphemot, Dora Posfai, Emily R. Derbyshire
Journal of Clinical Investigation (2016) Vol. 126, Iss. 6, pp. 2013-2020
Open Access | Times Cited: 35

Human Challenge Studies in Endemic Settings
Euzebiusz Jamrozik, Michael J. Selgelid
SpringerBriefs in ethics (2020)
Open Access | Times Cited: 32

Human challenge models: tools to accelerate the development of malaria vaccines
Martha M. Cooper, Claire Loiseau, James McCarthy, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 3, pp. 241-251
Closed Access | Times Cited: 31

Exploring Risks of Human Challenge Trials For COVID‐19
David Manheim, Witold Więcek, Virginia Schmit, et al.
Risk Analysis (2021) Vol. 41, Iss. 5, pp. 710-720
Open Access | Times Cited: 26

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
Melissa C. Kapulu, Domtila Kimani, Patricia Njuguna, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18

Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle
Rajneesh, Rahul Tiwari, Vishal Singh, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 10, pp. 1795-1814
Closed Access | Times Cited: 10

Expression of the Plasmodium falciparum Clonally Variant clag3 Genes in Human Infections
Sofía Mira-Martínez, Evi van Schuppen, Alfred Amambua‐Ngwa, et al.
The Journal of Infectious Diseases (2017) Vol. 215, Iss. 6, pp. 938-945
Open Access | Times Cited: 33

Transcriptome profiling reveals functional variation in Plasmodium falciparum parasites from controlled human malaria infection studies
Regina Hoo, Ellen Bruske, Sandra Dimonte, et al.
EBioMedicine (2019) Vol. 48, pp. 442-452
Open Access | Times Cited: 28

Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations
Mohamed Farouk Chughlay, Samantha Akakpo, Anand Odedra, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 1, pp. 378-393
Open Access | Times Cited: 27

Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
Melissa C. Kapulu, Patricia Njuguna, Mainga Hamaluba, et al.
JCI Insight (2021) Vol. 6, Iss. 17
Open Access | Times Cited: 23

Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults
Matthew B. Laurens, Andrea A. Berry, Mark A. Travassos, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 12, pp. 1962-1966
Open Access | Times Cited: 23

Patterns of Heterochromatin Transitions Linked to Changes in the Expression of Plasmodium falciparum Clonally Variant Genes
Lucas Michel-Todó, Cristina Bancells, Núria Casas-Vila, et al.
Microbiology Spectrum (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 14

Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine
Oriana Kreutzfeld, Katja Müller, Kai Matuschewski
Frontiers in Cellular and Infection Microbiology (2017) Vol. 7
Open Access | Times Cited: 23

Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection
Susanne H. Hodgson, David Llewellyn, Sarah E. Silk, et al.
Frontiers in Microbiology (2016) Vol. 7
Open Access | Times Cited: 22

Scroll to top